INS and metabolic dysfunction-associated steatotic liver disease: A number of studies conducted in NAFLD patients showed both an impaired ability of insulin to suppress endogenous glucose production (indicating the presence of hepatic IR) and approximately 50% reduction in glucose disposal (a measure of whole-body insulin-sensitivity) [52].